IDEAYA Biosciences (IDYA) Competitors $25.28 +0.35 (+1.38%) As of 11:29 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA vs. ROIV, RVMD, GRFS, RYTM, LEGN, ABVX, AXSM, RNA, NUVL, and MRUSShould you be buying IDEAYA Biosciences stock or one of its competitors? The main competitors of IDEAYA Biosciences include Roivant Sciences (ROIV), Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Abivax (ABVX), Axsome Therapeutics (AXSM), Avidity Biosciences (RNA), Nuvalent (NUVL), and Merus (MRUS). These companies are all part of the "pharmaceutical products" industry. IDEAYA Biosciences vs. Its Competitors Roivant Sciences Revolution Medicines Grifols Rhythm Pharmaceuticals Legend Biotech Abivax Axsome Therapeutics Avidity Biosciences Nuvalent Merus Roivant Sciences (NASDAQ:ROIV) and IDEAYA Biosciences (NASDAQ:IDYA) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends. Which has more risk and volatility, ROIV or IDYA? Roivant Sciences has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, IDEAYA Biosciences has a beta of 0.12, suggesting that its stock price is 88% less volatile than the S&P 500. Do institutionals and insiders hold more shares of ROIV or IDYA? 64.8% of Roivant Sciences shares are held by institutional investors. Comparatively, 98.3% of IDEAYA Biosciences shares are held by institutional investors. 10.8% of Roivant Sciences shares are held by insiders. Comparatively, 2.5% of IDEAYA Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is ROIV or IDYA more profitable? IDEAYA Biosciences has a net margin of 0.00% compared to Roivant Sciences' net margin of -2,111.79%. Roivant Sciences' return on equity of -15.90% beat IDEAYA Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Roivant Sciences-2,111.79% -15.90% -14.95% IDEAYA Biosciences N/A -31.42%-29.45% Which has preferable earnings & valuation, ROIV or IDYA? Roivant Sciences has higher revenue and earnings than IDEAYA Biosciences. Roivant Sciences is trading at a lower price-to-earnings ratio than IDEAYA Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoivant Sciences$29.05M335.33-$171.98M-$0.70-20.38IDEAYA Biosciences$7M317.70-$274.48M-$3.79-6.70 Do analysts rate ROIV or IDYA? Roivant Sciences currently has a consensus target price of $17.67, suggesting a potential upside of 23.85%. IDEAYA Biosciences has a consensus target price of $42.85, suggesting a potential upside of 68.85%. Given IDEAYA Biosciences' higher probable upside, analysts clearly believe IDEAYA Biosciences is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roivant Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50IDEAYA Biosciences 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.81 Does the media favor ROIV or IDYA? In the previous week, IDEAYA Biosciences had 15 more articles in the media than Roivant Sciences. MarketBeat recorded 38 mentions for IDEAYA Biosciences and 23 mentions for Roivant Sciences. Roivant Sciences' average media sentiment score of 0.73 beat IDEAYA Biosciences' score of 0.52 indicating that Roivant Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Roivant Sciences 13 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IDEAYA Biosciences 9 Very Positive mention(s) 7 Positive mention(s) 12 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive SummaryRoivant Sciences beats IDEAYA Biosciences on 11 of the 17 factors compared between the two stocks. Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDYA vs. The Competition Export to ExcelMetricIDEAYA BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.22B$3.18B$5.82B$10.13BDividend YieldN/A2.32%5.69%4.62%P/E Ratio-6.6921.5074.8626.13Price / Sales317.70297.34467.6691.41Price / CashN/A45.3337.0859.91Price / Book2.079.6812.096.33Net Income-$274.48M-$53.32M$3.29B$270.76M7 Day Performance-6.57%0.87%1.42%3.50%1 Month Performance7.57%9.65%7.70%6.83%1 Year Performance-29.73%13.23%62.04%28.21% IDEAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDYAIDEAYA Biosciences4.0031 of 5 stars$25.28+1.4%$42.85+69.5%-31.1%$2.22B$7M-6.6880Analyst ForecastAnalyst RevisionROIVRoivant Sciences2.8286 of 5 stars$11.93-0.1%$16.50+38.3%+16.4%$8.15B$29.05M-17.04860News CoverageOptions VolumeRVMDRevolution Medicines4.2667 of 5 stars$37.97-0.9%$69.92+84.2%+11.0%$7.10B$11.58M-8.44250Trending NewsAnalyst ForecastAnalyst RevisionGRFSGrifols3.9747 of 5 stars$9.97+1.0%$10.30+3.3%+9.0%$6.85B$7.81B8.5223,822News CoveragePositive NewsRYTMRhythm Pharmaceuticals3.1774 of 5 stars$103.15-1.0%$101.57-1.5%+98.6%$6.85B$130.13M-34.27140Positive NewsLEGNLegend Biotech3.2956 of 5 stars$34.73+1.0%$74.22+113.7%-32.0%$6.41B$627.24M-39.472,609Positive NewsABVXAbivax2.3345 of 5 stars$81.03-0.7%$92.33+13.9%+631.6%$6.12BN/A0.0061News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Gap DownAXSMAxsome Therapeutics4.9162 of 5 stars$121.28-0.4%$178.00+46.8%+35.1%$6.05B$385.69M-23.92380Positive NewsInsider TradeRNAAvidity Biosciences2.127 of 5 stars$46.58-4.1%$67.00+43.8%+1.2%$5.99B$10.90M-13.08190News CoverageAnalyst ForecastInsider TradeGap UpNUVLNuvalent3.0322 of 5 stars$76.58+0.7%$120.80+57.7%-4.0%$5.52BN/A-15.6340Positive NewsMRUSMerus2.9344 of 5 stars$65.84-0.4%$88.75+34.8%+38.8%$4.98B$36.13M-11.9737Positive News Related Companies and Tools Related Companies Roivant Sciences Alternatives Revolution Medicines Alternatives Grifols Alternatives Rhythm Pharmaceuticals Alternatives Legend Biotech Alternatives Abivax Alternatives Axsome Therapeutics Alternatives Avidity Biosciences Alternatives Nuvalent Alternatives Merus Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDYA) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDYA Stock Alerts